KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Other Accumulated Expenses (2016 - 2026)

Novartis Ag's Other Accumulated Expenses history spans 15 years, with the latest figure at -$100.0 million for Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses changed N/A to -$100.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$100.0 million, a N/A change, with the full-year FY2023 number at $516.0 million, down 38.28% from a year prior.
  • Other Accumulated Expenses hit -$100.0 million in Q1 2026 for Novartis Ag, down from -$23.0 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for NVS hit a ceiling of $2.6 billion in Q2 2022 and a floor of -$100.0 million in Q1 2026.
  • Historically, Other Accumulated Expenses has averaged $774.0 million across 4 years, with a median of $320.5 million in 2022.
  • Biggest five-year swings in Other Accumulated Expenses: skyrocketed 35.06% in 2022 and later crashed 360.0% in 2024.
  • Tracing NVS's Other Accumulated Expenses over 4 years: stood at $836.0 million in 2022, then plummeted by 38.28% to $516.0 million in 2023, then tumbled by 104.46% to -$23.0 million in 2024, then tumbled by 334.78% to -$100.0 million in 2026.
  • Business Quant data shows Other Accumulated Expenses for NVS at -$100.0 million in Q1 2026, -$23.0 million in Q1 2024, and $516.0 million in Q4 2023.